Phase 2 Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 18 years of age or older
- People who have had a tissue sample test confirming a diagnosis of breast cancer
- People whose breast cancer has been assessed as a certain stage — specifically, the tumour can be any of several sizes, lymph nodes may or may not be involved, but the cancer must not have spread to other parts of the body
- People who are reasonably well and able to carry out daily activities, based on a standard health scale used in cancer research (rated 0 to 2 out of 5)
- People who are willing and able to sign a written consent form that has been approved by an ethics review board
- People who are able to complete all required tests listed in the trial
- People who are willing to return to the enrolling hospital or clinic for follow-up visits during the active monitoring period
- People for whom radiation therapy for breast cancer has been recommended as part of their treatment
Who may not be able to join:
- People who have a medical reason why radiation therapy would not be safe for them
- People who have serious ongoing health conditions that, in the treating doctor's judgement, would make participation inappropriate or make it hard to accurately assess the safety of the treatments
- People with uncontrolled health issues, such as an active infection, heart failure, unstable chest pain, irregular heart rhythm, or mental health or personal circumstances that could make it difficult to follow the trial requirements or give informed consent
- People with active lupus or scleroderma (serious autoimmune conditions affecting the body's tissues)
- People who are currently pregnant
- People who are capable of becoming pregnant and are not willing to use adequate contraception during the trial
- People who have previously received radiation therapy to the same breast or chest wall being treated
- People whose breast cancer has come back after previous treatment (recurrent breast cancer)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Carlos E. Vargas, MD, Mayo Clinic
Phone: 855-776-0015
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence of grade 3 or higher radiation treatment (RT) related adverse events
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.